Discordance Between Respiratory Drive and Sedation Depth in Critically Ill Patients Receiving Mechanical Ventilation

Amy L Dzierba, Anas M Khalil, Katrina L Derry, Purnema Madahar, Jeremy R Beitler, Amy L Dzierba, Anas M Khalil, Katrina L Derry, Purnema Madahar, Jeremy R Beitler

Abstract

Objectives: In mechanically ventilated patients, deep sedation is often assumed to induce "respirolysis," that is, lyse spontaneous respiratory effort, whereas light sedation is often assumed to preserve spontaneous effort. This study was conducted to determine validity of these common assumptions, evaluating the association of respiratory drive with sedation depth and ventilator-free days in acute respiratory failure.

Design: Prospective cohort study.

Setting: Patients were enrolled during 2 month-long periods in 2016-2017 from five ICUs representing medical, surgical, and cardiac specialties at a U.S. academic hospital.

Patients: Eligible patients were critically ill adults receiving invasive ventilation initiated no more than 36 hours before enrollment. Patients with neuromuscular disease compromising respiratory function or expiratory flow limitation were excluded.

Interventions: Respiratory drive was measured via P0.1, the change in airway pressure during a 0.1-second airway occlusion at initiation of patient inspiratory effort, every 12 ± 3 hours for 3 days. Sedation depth was evaluated via the Richmond Agitation-Sedation Scale. Analyses evaluated the association of P0.1 with Richmond Agitation-Sedation Scale (primary outcome) and ventilator-free days.

Measurements and main results: Fifty-six patients undergoing 197 bedside evaluations across five ICUs were included. P0.1 ranged between 0 and 13.3 cm H2O (median [interquartile range], 0.1 cm H2O [0.0-1.3 cm H2O]). P0.1 was not significantly correlated with the Richmond Agitation-Sedation Scale (RSpearman, 0.02; 95% CI, -0.12 to 0.16; p = 0.80). Considering P0.1 terciles (range less than 0.2, 0.2-1.0, and greater than 1.0 cm H2O), patients in the middle tercile had significantly more ventilator-free days than the lowest tercile (incidence rate ratio, 0.78; 95% CI, 0.65-0.93; p < 0.01) or highest tercile (incidence rate ratio, 0.58; 95% CI, 0.48-0.70; p < 0.01).

Conclusions: Sedation depth is not a reliable marker of respiratory drive during critical illness. Respiratory drive can be low, moderate, or high across the range of routinely targeted sedation depth.

Conflict of interest statement

Dr. Beitler’s institution received funding from the National Institutes of Health (NIH); he received funding from Hamilton Medical and Sedana Medical; he received support for article research from the NIH. Drs. Dzierba, Khalil, Derry, and Madahar have disclosed that they do not have any potential conflicts of interest.

Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Figures

Figure 1.. P 0.1 and Richmond Agitation-Sedation…
Figure 1.. P0.1 and Richmond Agitation-Sedation Scale (RASS).
Overlaid box-and-whisker and scatter plot. Boxes represent median with interquartile range; whiskers extend 1.5 times the interquartile range beyond the first and third quartiles per the Tukey method. Diamonds represent mean values. Circles indicate individual observations; total of 197 observations were performed and all displayed. P0.1 values within each RASS level were randomly jittered to facilitate visualization. During the study period, the highest RASS observed was +1.
Figure 2.. Respiratory drive is poorly correlated…
Figure 2.. Respiratory drive is poorly correlated with sedation depth.
Pearson and Spearman correlations for cross-sectional relationship between P0.1 and sedation depth assessed via Richmond Agitation-Sedation Scale (RASS). Higher RASS corresponds to increased arousal (lighter sedation depth).
Figure 3.. Both high and low respiratory…
Figure 3.. Both high and low respiratory drive, compared to moderate drive, are associated with fewer ventilator-free days.
(A) Overlaid box-and whisker and scatter plots of all P0.1 values for each patient; red diamonds represent mean values, and circles indicate values from individual observations. Boxes represent median with interquartile range; whiskers extend 1.5 times the interquartile range beyond the first and third quartiles per the Tukey method. Shaded vertical bars indicate number of ventilator-free days for each patient (secondary Y-axis). Patients are sorted by number of ventilator free days and average P0.1 value to aid interpretation. (B) Locally estimated scatterplot smoothing (LOESS) regression line with 95% confidence bands for model associating P0.1 with ventilator-free days.

References

    1. Reade MC, Finfer S: Sedation and delirium in the intensive care unit. N Engl J Med 2014; 370:444–454
    1. Devlin JW, Skrobik Y, Gélinas C, et al.: Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46:e825–e873
    1. Chanques G, Kress JP, Pohlman A, et al.: Impact of ventilator adjustment and sedation-analgesia practices on severe asynchrony in patients ventilated in assist-control mode. Crit Care Med 2013; 41:2177–2187
    1. Hanidziar D, Bittner EA: Sedation of mechanically ventilated COVID-19 patients: challenges and special considerations. Anesth Analg 2020; 131:e40–e41
    1. Payen JF, Chanques G, Mantz J, et al.: Current practices in sedation and analgesia for mechanically ventilated critically Ill patients. Anesthesiology 2007; 106:687–695
    1. Mehta S, Burry L, Fischer S, et al.: Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006; 34:374–380
    1. Hansen-Flaschen JH: Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA 1991; 266:2870–2875
    1. Rhoney DH, Murry KR: National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003; 18:139–145
    1. Marini JJ: Dynamic hyperinflation and auto-positive end-expiratory pressure: lessons learned over 30 years. Am J Respir Crit Care Med 2011; 184:756–762
    1. Beitler JR, Sands SA, Loring SH, et al.: Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria. Intensive Care Med 2016; 42:1427–1436
    1. Levine S, Nguyen T, Taylor N, et al.: Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008; 358:1327–1335
    1. Jaber S, Petrof BJ, Jung B, et al.: Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 2011; 183:364–371
    1. Goligher EC, Fan E, Herridge MS, et al.: Evolution of diaphragm thickness during mechanical ventilation: impact of inspiratory effort. Am J Respir Crit Care Med 2015; 192:1080–1088
    1. Reynolds SC, Meyyappan R, Thakkar V, et al.: Mitigation of ventilator-induced diaphragm atrophy by transvenous phrenic nerve stimulation. Am J Respir Crit Care Med 2017; 195:339–348
    1. Goligher EC, Dres M, Patel BK, et al.: Lung and diaphragm-protective ventilation. Am J Respir Crit Care Med 2020; 202:950–961
    1. Shehabi Y, Bellomo R, Reade MC, et al.: Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med 2012; 186:724–731
    1. Treggiari MM, Romand J-A, Yanez ND, et al.: Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med 2009; 37:2527–2534
    1. Whitelaw WA, Derenne JP, Milic-Emili J: Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol 1975; 23:181–199
    1. Whitelaw WA, Derenne JP: Airway occlusion pressure. J Appl Physiol 1993; 74:1475–1483
    1. Telias I, Damiani F, Brochard L: The airway occlusion pressure (P0.1) to monitor respiratory drive during mechanical ventilation: increasing awareness of a not-so-new problem. Intensive Care Med 2018; 44:1532–1535
    1. Telias I, Junhasavasdikul D, Rittayamai N, et al.: Airway occlusion pressure as an estimate of respiratory drive and inspiratory effort during assisted ventilation. Am J Respir Crit Care Med 2020; 201:1086–1098
    1. Slutsky AS, Villar J: Early paralytic agents for ARDS? Yes, No, and Sometimes. N Engl J Med 2019; 380:2061–2063
    1. Huang DT, Angus DC, Moss M, et al.: Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome. Ann Am Thorac Soc 2017; 14:124–133
    1. Sottile PD, Albers D, Higgins C, et al.: The association between ventilator dyssynchrony, delivered tidal volume, and sedation using a novel automated ventilator dyssynchrony detection algorithm. Crit Care Med 2018; 46:e151–e157
    1. Kuhlen R, Hausmann S, Pappert D, et al.: A new method for P0.1 measurement using standard respiratory equipment. Intensive Care Med 1995; 21:554–560
    1. Kuhlen R, Mohnhaupt R, Slama K, et al.: Validation and clinical application of a continuous P0.1 measurement using standard respiratory equipment. Technol Health Care 1996; 4:415–424
    1. Conti G, Cinnella G, Barboni E, et al.: Estimation of occlusion pressure during assisted ventilation in patients with intrinsic PEEP. Am J Respir Crit Care Med 1996; 154:907–912
    1. Kera T, Aihara A, Inomata T: Reliability of airway occlusion pressure as an index of respiratory motor output. Respir Care 2013; 58:845–849
    1. Pandharipande PP, Pun BT, Herr DL, et al.: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298:2644–2653
    1. Riker RR, Shehabi Y, Bokesch PM, et al.: Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301:489–499
    1. Shehabi Y, Howe BD, Bellomo R, et al.: Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 2019; 380:2506–2517
    1. Kawazoe Y, Miyamoto K, Morimoto T, et al.: Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial. JAMA 2017; 317:1321–1328
    1. Barr J, Fraser GL, Puntillo K, et al.: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41:263–306
    1. Schoenfeld DA, Bernard GR, ARDS Network: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30:1772–1777
    1. Kress JP, Hall JB: The changing landscape of ICU sedation. JAMA 2012; 308:2030–2031
    1. Spinelli E, Mauri T, Beitler JR, et al.: Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Med 2020; 46:606–618
    1. Vaschetto R, Cammarota G, Colombo D, et al.: Effects of propofol on patient-ventilator synchrony and interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med 2014; 42:74–82
    1. Khamiees M, Amoateng-Adjepong Y, Manthous CA: Propofol infusion is associated with a higher rapid shallow breathing index in patients preparing to wean from mechanical ventilation. Respir Care 2002; 47:150–153
    1. Goodman NW, Black AMS, Carter JA: Some ventilatory effects of propofol as sole anesthetic agent. Br J Anaesth 1987; 59:1497–1503
    1. Forster A, Gardaz JP, Suter PM, et al.: Respiratory depression by midazolam and diazepam. Anesthesiology 1980; 53:494–497
    1. Berggren L, Eriksson I, Mollenholt P, et al.: Changes in respiratory pattern after repeated doses of diazepam and midazolam in healthy subjects. Acta Anaesthesiol Scand 1987; 31:667–672
    1. Morel DR, Forster A, Bachmann M, et al.: Effect of intravenous midazolam on breathing pattern and chest wall mechanics in human. J Appl Physiol 1984; 57:1104–1110
    1. Conti G, Ranieri VM, Costa R, et al.: Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study. Crit Care 2016; 20:206.
    1. Drummond GB, Duncan MK: Abdominal pressure during laparoscopy: effects of fentanyl. Br J Anaesth 2002; 88:384–388
    1. Murciano D, Aubier M, Bussi S, et al.: Comparison of esophageal, tracheal, and mouth occlusion pressure in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1982; 126:837–841
    1. Beloncle F, Piquilloud L, Olivier P-Y, et al.: Accuracy of P0.1 measurements performed by ICU ventilators: a bench study. Ann Intensive Care 2019; 9:104.
    1. Alberti A, Gallo F, Fongaro A, et al.: P0.1 is a useful parameter in setting the level of pressure support ventilation. Intensive Care Med 1995; 21:547–553
    1. Perrigault PF, Pouzeratte YH, Jaber S, et al.: Changes in occlusion pressure (P0.1) and breathing pattern during pressure support ventilation. Thorax 1999; 54:119–123
    1. Iotti GA, Brunner JX, Braschi A, et al.: Closed-loop control of airway occlusion pressure at 0.1 second (P0.1) applied to pressure-support ventilation: algorithm and application in intubated patients. Crit Care Med 1996; 24:771–779
    1. Sklar MC, Burns K, Rittayamai N, et al.: Effort to breathe with various spontaneous breathing trial techniques: a physiological meta-analysis. Am J Respir Crit Care Med 2017; 195:1477–1485
    1. Yoshida T, Torsani V, Gomes S, et al.: Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med 2013; 188:1420–1427
    1. Goligher EC, Brochard LJ, Reid WD, et al.: Diaphragmatic myotrauma: a mediator of prolonged ventilation and poor patient outcomes in acute respiratory failure. Lancet Respir Med 2019; 7:90–98
    1. Telias I, Beitler JR: Reverse triggering, the rhythm dyssynchrony: potential implications for lung and diaphragm protection. Am J Respir Crit Care Med 2021; 203:5–6

Source: PubMed

3
S'abonner